<p>Schizophrenia develops in one in every four individuals with a pathogenic 22q11.2 deletion, yet the genetic modifiers influencing the manifestation of schizophrenia in this high-risk group remain incompletely understood. Here, we identify rare tandem repeat expansions (TREs) as significant contributors to schizophrenia risk in this population. Genome sequencing of 438 unrelated individuals with 22q11.2 deletions revealed a marked enrichment of rare genic TREs among those with schizophrenia, with effect sizes comparable to common polygenic risk. These TREs are disproportionately located in intronic and splice-adjacent regions relative to other genomic regions, with evidence suggesting that they disrupt gene regulation through mechanisms including altered methylation and splicing. Cell-type-specific analyses indicate that TREs are primarily associated with differentially expressed genes in excitatory and inhibitory neurons in the prefrontal cortex. Affected genes, including <i>DLGAP2</i> and <i>DMPK</i>, are involved in neurodevelopment and synaptic organization. These findings extend the role of TREs as genetic modifiers, providing new insights into the molecular mechanisms underlying schizophrenia in this ultra-high-risk population and into the broader biology of idiopathic schizophrenia.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Genome-wide tandem repeat expansions modify schizophrenia risk in the presence of a 22q11.2 deletion

  • Muyang Cheng,
  • Yue Yin,
  • Worrawat Engchuan,
  • Tracy Heung,
  • Kathleen Angkustsiri,
  • Stylianos E. Antonarakis,
  • Marco Armando,
  • Carrie E. Bearden,
  • Massimo Biondi,
  • Erik Boot,
  • Jeroen Breckpot,
  • Elemi Breetvelt,
  • Tiffany Busa,
  • Nancy Butcher,
  • Antonino Buzzanca,
  • Linda Campbell,
  • Miri Carmel,
  • Arango Celso,
  • Eva W. C. Chow,
  • Isabelle Cleynen,
  • T. Blaine Crowley,
  • Joseph F. Cubells,
  • David Cutler,
  • Bruno Dallapiccola,
  • María Angeles de la Fuente Sanches,
  • M. Cristina Digilio,
  • Stephan Eliez,
  • Beverly S. Emanuel,
  • Michael P. Epstein,
  • Rens Evers,
  • Luis Fernandez,
  • Ania Fiksinski,
  • Rosemarie Fritsch,
  • Fernando García Algas,
  • Sixto García-Miñaúr,
  • Elizabeth Goldmuntz,
  • Doron Gothelf,
  • Raquel E. Gur,
  • Damian Heine-Suñer,
  • Matthew S. Hestand,
  • Stephen Hooper,
  • Andrea Jin,
  • H. Richard Johnston,
  • Wendy R. Kates,
  • Leila Kushan-Wells,
  • Alejandra Laorden-Nieto,
  • Guido Lattanzi,
  • Jhih-Rong Lin,
  • Bruno Marino,
  • Christian R. Marshall,
  • Kathryn L. McCabe,
  • Donna McDonald-McGinn,
  • Daniel McGinn,
  • Ehod Mekori,
  • Elena Michaelovsky,
  • Daniella Miller,
  • Jaume Morey Canyelles,
  • Kieran C. Murphy,
  • Declan G. Murphy,
  • Claudia Ornstein,
  • Michael J. Owen,
  • Maria Pontillo,
  • Carolina Putotto,
  • Gabriela M. Repetto,
  • Maude Schneider,
  • Kelly Schoch,
  • Vandana Shashi,
  • Lijie Shi,
  • Candice Silversides,
  • Ann Swillen,
  • Oanh T. Tran,
  • Marta Unolt,
  • Therese van Amelsvoort,
  • Marianne B. M. van den Bree,
  • Esther, D. A. van Duin,
  • Elfi Vergaelen,
  • Joris R. Vermeesch,
  • Stefano Vicari,
  • Claudia Vingerhoets,
  • Jacob Vorstman,
  • Yujue Wang,
  • Tao Wang,
  • Ronnie Weinberger,
  • Abraham Weizman,
  • Nigel M. Williams,
  • Elaine H. Zackai,
  • Zhengdong Zhang,
  • Yingjie Zhao,
  • Deyou Zheng,
  • Michael Zwick,
  • Bernice E. Morrow,
  • Anne S. Bassett,
  • Ryan K. C. Yuen

摘要

Schizophrenia develops in one in every four individuals with a pathogenic 22q11.2 deletion, yet the genetic modifiers influencing the manifestation of schizophrenia in this high-risk group remain incompletely understood. Here, we identify rare tandem repeat expansions (TREs) as significant contributors to schizophrenia risk in this population. Genome sequencing of 438 unrelated individuals with 22q11.2 deletions revealed a marked enrichment of rare genic TREs among those with schizophrenia, with effect sizes comparable to common polygenic risk. These TREs are disproportionately located in intronic and splice-adjacent regions relative to other genomic regions, with evidence suggesting that they disrupt gene regulation through mechanisms including altered methylation and splicing. Cell-type-specific analyses indicate that TREs are primarily associated with differentially expressed genes in excitatory and inhibitory neurons in the prefrontal cortex. Affected genes, including DLGAP2 and DMPK, are involved in neurodevelopment and synaptic organization. These findings extend the role of TREs as genetic modifiers, providing new insights into the molecular mechanisms underlying schizophrenia in this ultra-high-risk population and into the broader biology of idiopathic schizophrenia.